Skip to content

Posts by Ebru Oral, PhD


Dr. Oral received her BS degree from Bogazi├ži University in chemical engineering. She did her graduate work under the direction of Dr. Nicholas Peppas at Purdue University with specialization in polymeric biomaterials for therapeutic systems and received her PhD in chemical engineering in 2003. She did her post-doctoral training in orthopaedic biomaterials at the Harris Orthopaedics Laboratory from 2003 to 2005 on antioxidant stabilization methods of cross-linked polyethylenes for joint implants. Her post-doctoral work received the HAP Paul Award of the International Society for Technology in Arthroplasty. She was appointed an instructor in 2005 and focused on improving the mechanical strength of current polymeric materials used in joint implants and medical devices. She was named American Academy of Orthopaedics Surgeons/National Institutes of Health Young Investigator on Wear and Osteolysis in 2007 and she again received the HAP Paul Award of the ISTA in 2011. She was named a Claflin Distinguished Scholar at Mass General in 2011 and became a Lifetime Honorary Member of the International Society for Technology in Arthroplasty in 2013. She was promoted to assistant professor in orthopaedic surgery at Harvard Medical School in 2013 and focuses on addressing musculoskeletal problems using material strategies while leading the polymeric development work at Harris Orthopaedics Laboratory. She has published over 40 peer-reviewed papers and numerous book chapters. She is also an inventor of a number of material technologies for joint implants with over 90 patents and patent applications. In addition to her research, she is an educator to biomedical engineering technicians, post-doctoral fellows, medical students and colleagues, technicians and technologists.

Orthopaedic Care at Mass General

At Mass General, our world-class physicians and surgeons treat the full spectrum of musculoskeletal conditions throughout the body, from sprains and strains on the athletic field to carpal tunnel syndrome. Our team offers innovative, research-based treatments that range from limb-saving oncological procedures to complex spinal reconstruction.